Login to Your Account

Regulatory NEWS

The nomination of Seema Verma to the administrator of CMS came with many of the typical tough questions and a concomitant reluctance to answer directly at times.

KARACHI, Pakistan – Facing a chronic shortage of regulations, the biopharmaceutical industry in Pakistan is struggling to get traction despite widespread need and huge market potential.

From the FDA spying on its scientists to U.S. presidents overturning their predecessor's orders on specific types of medical research, politics and science frequently are uncomfortable bedfellows in government.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: